DekaBank Deutsche Girozentrale’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,000
| Closed | -$121K | – | 1301 |
|
|
2023
Q1 | $121K | Hold |
14,000
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q4 | $153K | Hold |
14,000
| – | – | ﹤0.01% | 1261 |
|
|
2022
Q3 | $182K | Hold |
14,000
| – | – | ﹤0.01% | 1242 |
|
|
2022
Q2 | $175K | Hold |
14,000
| – | – | ﹤0.01% | 1211 |
|
|
2022
Q1 | $198K | Buy |
14,000
+1,300
| +10% | +$18.4K | ﹤0.01% | 1210 |
|
|
2021
Q4 | $384K | Buy |
12,700
+300
| +2% | +$9.07K | ﹤0.01% | 1155 |
|
|
2021
Q3 | $366K | Hold |
12,400
| – | – | ﹤0.01% | 1111 |
|
|
2021
Q2 | $344K | Hold |
12,400
| – | – | ﹤0.01% | 1127 |
|
|
2021
Q1 | $351K | Hold |
12,400
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q4 | $465K | Buy |
+12,400
| New | +$465K | ﹤0.01% | 1035 |
|